21240 P. Leif Bergsagel: Need akt? Some myelomas do. Blood 112/8 (2008), 3004-3005.

21225 Guido Bisping/.../Martin Kropff: Neue Aspekte zur Therapie des
multiplen Myeloms. Literaturverzeichnis.
Krankenhauspharmazie 9 (2009), 2p.

21165 David Dingli/.../Morie Gertz: Relationship between depth of
response and outcome in multiple myeloma. J. Clin. Onc. 25/31 (2007), 4933-4937.

21169 David Dingli/.../Morie Gertz: In vivo and in silico studies on single
versus multiple transplants for multiple myeloma.
Cancer Science 98/5 (2007), 734-739.

21163 David Dingli/.../Z. Bajzer: Dynamics of multiple myeloma tumor
therapy with a recombinant measles virus.
Cancer Gene Therapy ... (2009), 1-10.

21391 Karolyn Gazella: Pioneering biochemist Bharat B. Aggarwal,
PhD, of the M.D. Anderson Cancer Center, on discovering novel and
effective cancer treatments. Natural Med. J. 1/4 (2009), 1-2.

21229 Axel Glasmacher: Infobrief zu Velcade (Bortezomid). Internet 2005, 9p.

21361 Hartmut Goldschmidt: VISTA-Studie läutet Paradigmenwechsel
beim multiplen Myelom ein. Internet 2009, 4p.

18461 Carl Gregory: Advances in myeloma therapy - breaking the cycle.
Blood 109/5 (2007), 1798.

21376 Teru Hideshima/.../Kenneth Anderson: Bortezomib induces canonical
nuclear factor-kappa-B activation in multiple myeloma cells.
Blood 114 (2009), 1046-1052.

21199 Leonora Houet/Hendrik Veelken: Active immunotherapy of multiple myeloma.
Europ. J. Cancer 42 (2006), 1653-1660.

21205 Michael Hundemer: Immuntherapie. Internet 2008, 24p.

21239 Prashant Kapoor/.../S. Rajkumar: Impact of risk stratification on
outcome among patients with multiple myeloma receiving initial therapy
with lenalidomide and dexamethasone. Blood 114/3 (2009), 518-521.

21460 Z. Kapsztas/.../L. Cherem: Bortezomib successfully reverses
early recurrence of light-chain deposition disease in a renal
allograft - a case report. Transplant Proc. 41/10 (2009), 4407-4410.
The maintenance therapy included curcumin (9 g daily).
See also the discussion on Margaret's blog: tinyurl.com/ydp8ye8.

21161 Shaji Kumar/.../Morie Gertz: Improved survival in multiple myeloma
and the impact of novel therapies. Blood 1 November 2007, 5p.

21162 Shaji Kumar/.../S. Rajkumar: Mobilization in myeloma revisited -
IMWG consensus perspectives on stem cell collection following initial
therapy with thalidomide-, lenalidomide, or bortezomib-containing
regimes. Blood 6 September 2009, 8p.

21238 Martha Lacy/.../S. Rajkumar: Pomalidomide (CC4047) plus low-dose
dexamethasone as therapy for relapsed multiple myeloma.
J. Clin. Onc. ... (2000), 7p.

21234 Sagar Lonial (ed.): Myeloma therapy - pursuing the plasma cell.
Humana 2008, 660p. Eur 95.

21202 Minnie Luongo: Una concreta speranza di cura per il mieloma multiplo.
Internet 2008, 2p. La lenalidomide.

21416 Huihui Ma/.../Markus Mapara: Cucurbitacin I (JSI-124) has
potent anti-myeloma effects independent of its inhibition of
JAK2-induced STAT3 activation.
Blood ASH 2007 Abstracts, 1p.

21375 Joseph Negri/.../Constantine Mitsiades: In vitro anti-myeloma
activity of the Aurora kinase inhibitor VE-465.
Brit. J. Haem. 147/5 (2009), 672-676.

21194 Antonio Palumbo: Dalla terapia ad alte dosi, alla talidomide,
agli inibitori del proteasoma, al controllo della malattia ossea -
una storia terapeutica in evoluzione. Internet ca. 2008, 25p.

21378 Juwon Park/.../Sung-soo Yoon: Curcumin in combination with
bortezomib synergistically induced apoptosis in human multiple
myeloma U266 cells. Mol. Oncology 2 (2008), 317-326.

21226 D. Peest/A. Ganser: Therapie des multiplen Myeloms.
Internist 48 (2007), 1343-1348.

21203 Marc Raab: Neue Substanzen in der Therapie des multiplen Myeloms.
Internet 2008, 29p.

21258 S. Rajkumar/Robert Kyle: Multiple myeloma - diagnosis and treatment.
Mayo Clin. Proc. 80/10 (2005), 1371-1382.

21233 S. Rajkumar/Robert Kyle (ed.): Treatment of multiple myeloma and
related disorders. Cambridge UP 2009, 200p. Eur 62.

21227 Paul Richardson/.../Kenneth Anderson: New drugs for myeloma.
The Oncologist 12 (2007), 664-689.

21160 Carlo Vigliani: La lenalidomide - nuovo farmaco contro il
mieloma multiplo. Internet 2008, 1p.

21600 Weiyan Zheng/.../Zhen Cai: Bortezomib in combination with
dexamethasone and subsequent thalidomide for newlydiagnosed
multiple myeloma - a Chinese experience.
Leukemia Res. 33 (2009), 1615-1618.

21362 ZZ: Bortezomib in der Initialtherapie des multiplen Myeloms.
Internet 2008, 4p.

21172 ZZ: Il tallone d'Achille del mieloma multiplo. Internet 2009, 1p.